Efficient Predictor for Immunotherapy Efficacy: Detecting Pan‐Clones Effector Tumor Antigen‐Specific T Cells in Blood by Nanoparticles Loading Whole Tumor Antigens (Adv. Sci. 2/2025)
Source abstract
Abstract
Efficient Predictor for Immunotherapy Efficacy In article number 2409913, Xin Tong, Mi Liu, Jun Zhao, and co-workers present a new biomarker to predict therapeutic efficacy: detecting the amount of effector tumor antigen-specific T cells (ETASTs) in peripheral blood of cancer patients. ETATSs increase in blood of cancer patient that are responsive to immunotherapy, but not increase in blood of non-responders.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Immunotherapy and Immune Responses · Monoclonal and Polyclonal Antibodies Research · vaccines and immunoinformatics approaches
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References
Reference metadata was not supplied for this record.